Floatz logo

FILGRASTIM

Mediastinal Neoplasms

Nicola Goekbugetprotein_peptidePhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mediastinal Neoplasms cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Nasser Hanna, M.D.
Phase 4BB
VINDESINE
Nicola Goekbuget
Phase 4BB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Nicola Goekbuget
Phase 4BB
Ifosfamide
Nicola Goekbuget
Phase 4BB
ETOPOSIDE
Nicola Goekbuget
Phase 4BB

View all 15 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →